| Typicality: | 0.377 |
| Saliency: | 0.299 |
| in canada | 5 | location |
| recently | 3 | temporal |
| in 2015 | 2 | temporal |
| vaccine → be approved in → europe | 13 |
| vaccine → be approved by → the european medicines agency | 10 |
| vaccine → be approved in → the european union | 4 |
| negative | neutral | positive |
| 0.061 | 0.521 | 0.418 |
| Raw frequency | 27 |
| Normalized frequency | 0.299 |
| Modifier score | 0.500 |
| Perplexity | 35.711 |